Aripiprazole effects on reward processing in deficit syndrome schizophrenia.
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2013
At a glance
- Drugs Aripiprazole (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 15 Jun 2012 Actual patient number is 20 according to ClinicalTrials.gov.
- 15 Jun 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 15 Jun 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.